National projects
| National Network of Renal Function Labs | |
| Proyecto | PMP22/00119 |
| Funding | Convocatoria de Proyectos de Medicina Personalizada -2022- |
| Duration | 2023-2025 |
| IP (PI) Esteban Porrini |
| Intrarenal ischemia: a new component of diabetic nephropathy | |
| FIS PI22/01673 | |
| Funding | Instituto de Salud Carlos III |
| Duración | 2022-2024 |
| IP (PI) Esteban Porrini; Rosa Rodríguez |
| Renal Disease in Obesity-Overweight-Metabolic Syndrome | |
| Long-Term Fellowship de la European Renal Association (ERA) 2021 | |
| Funding | European Renal Association |
| Duración | 2022-2024 |
| IP (PI) Ana Elena Rodriguez Rodríguez |
| Renal function measured in Advanced CKD patients: Precision Medicine in Nephrology in 2020 | |
| PIFUN PIFIISC20/53-FIISC | |
| Funding | European Renal Association |
| Duración | 2021-2023 |
| IP (PI) Beatriz Escamilla |
| Renal Dysfunction and Chronic Liver Disease: Prediction of the risk of adverse effects | |
| OA22/028 | |
| Funding | Fundación DISA |
| Duración | 2022-2023 |
| IP (PI) Carlos González Alayón |
| Obesity, Metabolic Syndrome And Renal Disease | |
| PI19/01756 | |
| Funding | Instituto de Salud Carlos III |
| Duration | 2020-2023 |
| PI | Esteban Porrini |
| Identification of rapid progressors towards chronic kidney disease in patients with autosomal dominant polycystic kidney disease: the role of measured glomerular filtration rate | |
| PI19/01200 | |
| Funding | Instituto de Salud Carlos III |
| Duration | 2020-2023 |
| PI | Sergio Luis Lima |
| Renal function loss in women in the absence of proteinuria | |
| FIS: PI16/01814 | |
| Funding | Instituto de Salud Carlos III |
| Duration | 2017-2020 |
| PI | Esteban Porrini |
| Glomerular hyperfiltration and the non-proteinuric pathway of GFR decline in type 2 diabetes. | |
| FIS: PI13/00342 | |
| Funding | Instituto de Salud Carlos III |
| Duration | 2014-2016 |
| PI | Esteban Porrini |
| Glomerular hyperfiltration, insulin resistance and the non-proteinuric pathway of GFR deline in type 2 diabetes. | |
| Funding | Fundación CajaCanarias |
| Duration | 2013-2015 |
| PI | Esteban Porrini |
| Evaluation of the error of estimated GFR in renal transplantation | |
| Funding | Senefro, Sociedad Española de Nefrología |
| Duration | 2012-2014 |
| PI | Esteban Porrini |
| Error in the dosification of carboplatin in cancer patients. Consequence of the error in the estimation of renal function. | |
| Funding | Fundación DISA |
| Duration | 2013-2015 |
| PI | Esteban Porrini |
| Open-label clinical trial of parallel groups, Phase III, to assess the antiproteinuric effect of vitamin D derivatives in patients with chronic kidney disease and vitamin D deficiency (NEFROVID clinical trial) | |
| Funding | Instituto de Salud Carlos III |
| Duration | 2012-2018 |
| PI Ana Aldea Perona; co-PI Esteban Porrini |
| Relationship between renal function to endothelial dysfunction in living donors, CONFUCIUS study | |
| Funding | TEVA Laboratory |
| Duration | 2016- |
| co-PI Esteban Porrini; Ana González Rinne |
| Unmasking progressors towards chronic kidney disease in autosomal dominant polycystic kidney disease ADPKD by measured renal function | |
| Funding | OTUSKA Laboratory |
| Duration | 2017- |
| PI Rosa Miquel; co-PI Esteban Porrini |
| Efficacy of the new formulation of tacrolimus on one daily dose LCTP “ENVARSUS®” to prevent post-transplant diabetes in patients at risk: a randomized, controlled and open pilot study | |
| Funding | CHIESI Laboratory |
| Duration | 2017- |
| PI Armando Torres; co-PI Esteban Porrini |
| Impact of renal reserve after living kidney donation | |
| PIFUN18/17 | |
| Funding | Fundación FIISC |
| Duration | 2017- |
| PI Ana González Rinne; co-PI Esteban Porrini |
| Effects of weight loss on renal function in obese patients with CKD undergoing bariatric surgery | |
| Hospital Universitario 12 de Octubre, Madrid | |
| Funding | Senefro, Sociedad Española de Nefrología |
| Duration | 2017- |
| PI Enrique Morales; co-PI Esteban Porrini |
Interational projects
| DOKI project: Diabetes Obesity and the Kidney | |
| 10107907, HORIZON-WIDERA-2021 | |
| Funding | European Research Executive Agency |
| Duración | 2023-2025 |
| IP (PI) Esteban Porrini (España); Mads Hornum (Dinamarca); Trond Jenssen (Noruega) |
| IMBRAIN Project | |
| FP7-REGPOT-2012-CT2012-316137-IMBRAIN | |
| Funding | European Union |
| Duration | 2013-2016 |
| PI | Esteban Porrini |
| Dose-response study of gevokizumab (S 078989) 3mg, 10mg, 30mg or 60mg in patients with type 2 diabetes and diabetic kidney disease (DKD) | |
| Funding | SERVIER Laboratory |
| Duration | 2015-2016 |
| co-PI | Esteban Porrini |
Collaborations
| The error of estimated GFR in patients with liver transplantation | |
| Collaboration with the Liver Transplant Unit, Hospital Nuestra Señora de la Candelaria, Santa Cruz de Tenerife | |
| PI Antonio González; co-PI Esteban Porrini |
| The error of estimated GFR in patients with liver cirrosis | |
| Collaboration with the Gastroenterology Department, Hospital Universitario de Canarias, La Laguna, Tenerife | |
| PI Manuel Hernández Guerra; co-PI Carlos González Alayón |
| Consequences of the bias of eGFR in acute heart failure | |
| Collaboration with the Cardiology Unit, Hospital Universitario de Canarias, La Laguna, Tenerife | |
| PI Martín García González; co-PI Pablo Jorge |
| The importance of measured GFR in patients with advanced CKD | |
| Collaboration with the Nefrology Department, Hospital Universitario de Alcorcón, Madrid | |
| PI Gema Fernández; co-PI Beatriz Escamilla |